Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PluroGel PN
- Development stage
- Unknown
- Lead developer
- PluroGen Therapeutics
- Modality
- Hydrogel Systems → Drug Delivery Systems, Small Molecules
- Administration
- Topical
01
Overview
PluroGel PN is a topical antibiotic wound dressing developed by PluroGen Therapeutics for the treatment of mildly infected diabetic foot ulcers. The product utilizes a unique combination of antibiotics (typically polymyxin B and neomycin) incorporated into the proprietary PluroGel platform, which is a concentrated, surfactant-based, water-soluble hydrogel. This platform is designed to maintain a moist wound healing environment while providing wound cleaning, hydration, and debriding properties. PluroGel PN has been evaluated in Phase 2 clinical trials (PGN-1300 and PGN-1300X) in the United States, aiming to address the significant unmet need for an FDA-approved topical antibiotic specifically indicated for infections in diabetic foot ulcers.
- Brand names
- PluroGel PN
- Other names
- PluroGel PN Topical Antibiotic
02
Targets
Bacterial Ribosome
Beyond the preview
Go deeper on PluroGel PN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PluroGel PN.